drugset / Trial / NCT01512225

Enhancing Breast Milk Production With Domperidone in Mothers of Preterm Neonates

NCT01512225

Phase 2 Completed 90 enrolled Sunnybrook Health Sciences Centre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of Domperidone in those mothers who are identified as having difficulty with breast milk production to meet the nutritional needs of their infant in the neonatal intensive are unit hospitalization setting, and to determine how it should be considered in the care of mothers and their preterm infants without causing undesirable effects to either the mother or infant.

Timeline

Start
2012-05
Primary completion
2015-10
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Domperidone Unknown 10 mg Oral

Indications

No indication recorded.